RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease.

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease.

Add to Collection
2022 Jul 14 Others Fist_Author_Year_PM

Full Author : ['Bellanti, Francesco', 'Lo Buglio, Aurelio', 'Dobrakowski, Michal', 'Kasperczyk, Aleksandra', 'Kasperczyk, Slawomir', 'Aich, Palok', 'Singh, Shivaram P', 'Serviddio, Gaetano', 'Vendemiale, Gianluigi']
Journal Title : World journal of gastroenterology
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

BACKGROUND: Sodium glucose cotransporter-2 inhibitors (SGLT2-I) are the most recently approved drugs for type 2 diabetes (T2D). Recent clinical trials of these compounds reported beneficial cardiovascular (CV) and renal outcomes. A major cause of vascular.....

Keywords : ["nonalcoholic fatty liver disease", "sodium glucose inhibitor", "liver steatosisfibrosisinflammation", "redox balance", "impact"]